Self-Start Triage Model for Post-Botox® Lower Urinary Tract Symptoms
Recruiting
Early Phase 1
Interventional Study
Overactive Bladder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 260 (estimated)
- Sponsor
- The Cleveland Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary objective of this study is to investigate whether providing a standing, take-home prescription for empiric Macrobid (self-start model) is superior to standard call-in/urgent care triage (triage model) among patients undergoing intradetrusor Botox®. Urinary tract infections. (UTIs) are the most common complication with intradetrusor Botox®, and patients have to call in to the triage lin…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Female patients of all races and ethnicities aged 18 years and older.
* Diagnosis of Overactive Bladder (OAB) and/or Urge Urinary Incontinence (UUI).
* Scheduled to receive intradetrusor onabotulinumtoxinA (Botox®) for symptom management.
* Has decision making capacity to prov…
Contacts